Pulmonx News

Pulmonx Initiated at Buy by Lake Street

Pulmonx Initiated at Buy by Lake Street

Dow JonesJun 4 11:36 ET

Lake Street Initiates Pulmonx(LUNG.US) With Buy Rating, Announces Target Price $12

Lake Street analyst Frank Takkinen initiates coverage on $Pulmonx(LUNG.US)$ with a buy rating, and sets the target price at $12.According to TipRanks data, the analyst has a success rate of 34.2% and

moomoo NewsJun 4 08:33 ET

Why We're Not Concerned About Pulmonx Corporation's (NASDAQ:LUNG) Share Price

With a price-to-sales (or "P/S") ratio of 4x Pulmonx Corporation (NASDAQ:LUNG) may be sending bearish signals at the moment, given that almost half of all Medical Equipment companies in the United Sta

Simply Wall StMay 30 08:28 ET

Pulmonx(LUNG.US) Officer Sells US$10,312.64 in Common Stock

$Pulmonx(LUNG.US)$ Officer Rose Geoffrey Beran sold 1,184 shares of common stock on May 22, 2024 at an average price of $8.71 for a total value of $10,312.64.Source: Announcement What is statement of

moomoo NewsMay 23 18:49 ET

Express News | Pulmonx Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersMay 6 17:03 ET

Pulmonx Corporation's Financial Outlook: Single-Product Reliance and Market Penetration Hurdles Threaten Profitability

TipRanksMay 5 02:00 ET

Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 3 09:43 ET

Pulmonx Is Maintained at Buy by Canaccord Genuity

Pulmonx Is Maintained at Buy by Canaccord Genuity

Dow JonesMay 2 15:26 ET

Canaccord Genuity Maintains Buy on Pulmonx, Lowers Price Target to $15

Canaccord Genuity analyst Jon Young maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $16 to $15.

BenzingaMay 2 15:16 ET

Pulmonx Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 57.23% Canaccord Genuity $16 → $15 Maintains Buy 04/03/2024 78.2% Piper Sandler $17 → $17 Reite

BenzingaMay 2 15:15 ET

C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday

U.S. stocks were higher, with the Dow Jones index gaining over 50 points on Thursday.Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rose sharply during Thursday's session after the company repo

BenzingaMay 2 10:28 ET

Pulmonx Surge After Strong 1Q Performance

By Dean Seal Shares of Pulmonx soared after the company logged a narrower first-quarter loss than analysts had been expecting. The stock was up 25% at $9.63 after the opening bell. Shares are still

WSJMay 2 09:45 ET

Express News | Pulmonx Shares Rise 28.3% After Q1 Revenue Beat

ReutersMay 2 09:32 ET

Market-Moving News May 2nd

ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ov

BenzingaMay 2 08:39 ET

Q1 2024 Pulmonx Corp Earnings Call

Yahoo FinanceMay 2 07:05 ET

Earnings Call: Pulmonx Sees 30% Sales Boost in Q1, Eyes $84M Annual Target

InvestingMay 2 06:59 ET

Express News | Pulmonx Corp Shares up 26.8% Premarket After Q1 Revenue Beat

ReutersMay 2 06:36 ET

Earnings Call Summary | Pulmonx(LUNG.US) Q1 2024 Earnings Conference

The following is a summary of the Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript:Financial Performance:Pulmonx reported Q1 2024 sales of $18.9 million, a 30% increase from the same period

moomoo AIMay 2 05:16 ET · Conference Call

Pulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ...

Yahoo FinanceMay 2 03:38 ET

Express News | Pulmonx Corp : Canaccord Genuity Cuts Target Price to $15 From $16

ReutersMay 2 03:25 ET